timolol has been researched along with enalapril in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (25.00) | 18.7374 |
| 1990's | 2 (10.00) | 18.2507 |
| 2000's | 7 (35.00) | 29.6817 |
| 2010's | 6 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Chen, L; He, Z; Li, H; Liu, J; Liu, X; Sui, X; Sun, J; Wang, Y; Zhang, W | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Habte, B | 1 |
| Jounela, AJ; Lumme, JA | 1 |
| Foss, PO; Fossbakk, B; Leren, P; Nordvik, B | 1 |
| Franklin, SS; Smith, RD | 2 |
| Vidt, DG | 1 |
| Gordeladze, JO; Jynge, P; Sellevold, OF | 1 |
| Abdellatef, HE; Ayad, MM; Hosny, MM; Shalaby, A | 1 |
| Fridriksdóttir, H; Loftsson, T; Stefánsson, E; Thorisdóttir, S | 1 |
2 review(s) available for timolol and enalapril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Advances in the medical management of renovascular hypertension.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Arteriosclerosis; Atenolol; Captopril; Dipeptides; Enalapril; Female; Humans; Hypertension, Renovascular; Male; Metoprolol; Middle Aged; Nadolol; Pindolol; Propanolamines; Propranolol; Renal Artery Obstruction; Renin-Angiotensin System; Saralasin; Timolol | 1984 |
5 trial(s) available for timolol and enalapril
| Article | Year |
|---|---|
The efficacy of hydrochlorothiazide, timolol and enalapril in Ethiopians with essential hypertension.
Topics: Adult; Double-Blind Method; Drug Therapy, Combination; Enalapril; Ethiopia; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Timolol | 1992 |
Combined action of enalapril or timolol with hydrochlorothiazide plus amiloride in hypertension.
Topics: Adult; Aged; Amiloride; Antihypertensive Agents; Clinical Trials as Topic; Drug Therapy, Combination; Enalapril; Female; Hemodynamics; Humans; Hydrochlorothiazide; Hypertension; Magnesium; Male; Middle Aged; Potassium; Timolol | 1987 |
The effect of enalapril and timolol on blood lipids. A randomized multicenter hypertension study in general practice in Norway.
Topics: Adult; Blood Pressure; Clinical Trials as Topic; Enalapril; Female; Humans; Hypertension; Lipids; Male; Middle Aged; Norway; Random Allocation; Timolol | 1988 |
Comparison of effects of enalapril plus hydrochlorothiazide versus standard triple therapy on renal function in renovascular hypertension.
Topics: Adult; Aged; Blood Pressure; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Male; Middle Aged; Renal Circulation; Timolol | 1985 |
A comparison of enalapril plus hydrochlorothiazide with standard triple therapy in renovascular hypertension.
Topics: Adult; Aged; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hydralazine; Hydrochlorothiazide; Hypertension, Renovascular; Kidney; Male; Middle Aged; Patient Dropouts; Prospective Studies; Random Allocation; Timolol | 1986 |
13 other study(ies) available for timolol and enalapril
| Article | Year |
|---|---|
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Prediction of volume of distribution values in human using immobilized artificial membrane partitioning coefficients, the fraction of compound ionized and plasma protein binding data.
Topics: Blood Proteins; Chemistry, Physical; Computer Simulation; Humans; Membranes, Artificial; Models, Biological; Pharmaceutical Preparations; Protein Binding; Tissue Distribution | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Beta-adrenergic signalling and threshold adrenaline concentration for induction of fibrillation in the perfused heart pretreated with antihypertensive drugs.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Cyclic AMP; Enalapril; Epinephrine; GTP-Binding Proteins; In Vitro Techniques; Male; Metoprolol; Perfusion; Potassium; Rats; Rats, Wistar; Receptors, Adrenergic, beta; Signal Transduction; Timolol; Verapamil | 1999 |
Spectrophotometric methods for determination of enalapril and timolol in bulk and in drug formulations.
Topics: Antihypertensive Agents; Drug Compounding; Enalapril; Eosine Yellowish-(YS); Methylcellulose; Palladium; Reproducibility of Results; Spectrum Analysis; Timolol | 2003 |
Enalaprilat and enalapril maleate eyedrops lower intraocular pressure in rabbits.
Topics: Administration, Topical; Animals; Antihypertensive Agents; Enalapril; Enalaprilat; Female; Intraocular Pressure; Male; Ophthalmic Solutions; Rabbits; Time Factors; Timolol; Tonometry, Ocular | 2010 |